Psychiatry Investig Search

CLOSE


Psychiatry Investig > Volume 23(3); 2026 > Article
Kwan, Cho, Park, Choi, and Kim: Effects of a Nature-Based Intervention on Cognitive Function in Older Adults With Mild Cognitive Impairment

Abstract

Objective

Mild cognitive impairment (MCI) represents a high-risk stage for dementia, yet limited non-pharmacological interventions are accessible. Although nature-based interventions have potential cognitive benefits, empirical validation for MCI populations remains limited. This study aims to address this gap.

Methods

Fifty older adults with MCI were recruited from a psychiatric outpatient clinic and local dementia centers. The intervention group included 25 participants who received a four-session nature-based intervention over 4 weeks, while controls, matched for age and sex, received no intervention. Pre- and post-tests assessed cognitive, emotional, physiological, and physical functions.

Results

Mini-Mental State Examination (MMSE) scores demonstrated a significant time×group interaction [F(1,45)=10.226, p=0.003]. The nature-based intervention group showed that MMSE scores increased significantly (t=-2.270, p=0.034). In contrast, the control group exhibited a significant decline (t=2.262, p=0.034). No significant time and group interactions were found for emotional, physiological, or physical outcomes.

Conclusion

This short-term, nature-based intervention yielded cognitive benefits in older adults with MCI, which supported its feasibility as an accessible, non-pharmacological intervention. Further longitudinal randomized controlled trials should confirm sustained effects across multiple domains.

INTRODUCTION

Age-related cognitive decline has become a major public health issue owing to global population aging, particularly in super-aged societies, such as South Korea, where over 20% of the population is aged 65 years or older [1]. This demographic trend is expected to intensify in the coming decades. Cognitive impairment in aging populations reduces an individual’s quality of life and imposes significant social and economic burdens [2].
Mild cognitive impairment (MCI), an intermediate stage between normal aging and dementia, is characterized by measurable cognitive deficits with maintained functional independence [3]. Early intervention is considered crucial for delaying or preventing progression to dementia and reducing long-term care needs.
However, pharmacological treatments for MCI have demonstrated limited efficacy and are frequently associated with adverse effects [4-7]. Although approved for Alzheimer’s disease, common drugs, such as cholinesterase inhibitors and N-methyl-D-aspartate receptor antagonists, have yielded inconsistent results among those with MCI [4,6]. Furthermore, current clinical guidelines advise against their routine use [8]. Recently, antiamyloid therapies, such as Donanemab and Lecanemab, have been approved; however, high cost, complex administration protocols, and risk of serious side effects, including cerebral hemorrhage and brain edema [9,10], limit their utility in real-world settings, which reinforces the need for non-pharmacological interventions.
Thus, non-pharmacological interventions focusing on modifiable lifestyle behaviors have gained attention as low-risk, nonpharmacological alternatives. Among these, nature-based interventions (NBIs) have emerged as possible approaches for supporting cognitive health among older adults with MCI.
Shanahan et al. [11] defined NBIs as structured activities that aim to engage individuals with natural environments to promote physical, mental health, and overall well-being. Jiang et al. [12] further characterized NBIs as integrative programs that incorporated sensory stimulation, physical activity, and emotional engagement to enhance overall health. These interventions aim to harness the multifaceted components of natural environments in combination with bodily movement, social interaction, and psychological stimulation to foster cognitive, emotional, and physical wellness.
Recent studies reported that NBIs may enhance cognitive and emotional outcomes in older adults [13-15]. Natural settings may stimulate the prefrontal cortex and attentional networks, which may promote neuroplasticity and support cognitive restoration [16-18]. These effects may be particularly relevant for individuals with MCI, who often exhibit early impairments in attention and executive function. NBIs also integrate physical activity and social interaction, both of which contribute to cognitive resilience, and offer a potentially further effective approach than single-component interventions [19,20].
Despite increasing interest, few experimental studies have examined the effects of NBIs specifically in older adults with MCI. Jun et al. [21] found no significant changes in cognitive function following a forest experience program, while Baek et al. [15] reported positive outcomes in a single-group design that lacked a control group.
Considering the research gaps and mixed findings, this study aimed to empirically investigate the effects of a NBI on cognitive function in older adults with MCI via a control group design matched for age and sex. Furthermore, this study sought to contribute to evidence-based preventive strategies for promoting cognitive health in aging populations with MCI.

METHODS

Study design

This study adopted an age- and sex-matched experimental-control group design. Individuals aged 60 years or older with a clinical diagnosis of MCI were recruited. Assessments of cognitive and emotional function, blood pressure, and physical performance were conducted pre- and post-intervention. The NBI program was implemented from April to October 2022. The experimental group engaged in weekly sessions for four weeks, with 3-5 individuals per group. The control group maintained their usual daily routines (Figure 1). This study was approved by the Institutional Review Board of Chuncheon Sacred Heart Hospital, Republic of Korea (Approval No. CHUNCHEON 2021-08-011).

Participants

Participants were recruited from outpatient clinics at the Department of Psychiatry, Chuncheon Sacred Heart Hospital, and via outreach to a local dementia care center. Eligible individuals were older adults clinically diagnosed with MCI by a board-certified psychiatrist. Those who expressed interest underwent preliminary screening to assess dementia-related indicators and confirm their eligibility via Clinical Dementia Rating (CDR), Global Deterioration Scale (GDS), Short Blessed Test (SBT), and Instrumental Activities of Daily Living (IADL).
Inclusion criteria were those who: 1) met the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for mild neurocognitive disorder [22], 2) had a clinical diagnosis of MCI based on Petersen’s criteria, subjective memory complaint, intact daily function, preserved general cognition, impaired memory for age, and absence of dementia [23], and 3) had a score of 0.5-1 or 2-4 points on the CDR [24] and GDS [25], respectively.
Exclusion criteria included those with 1) neurological disorders (e.g., epilepsy, Parkinson’s disease); 2) psychiatric disorders based on the DSM-5, which included bipolar disorder or substance/alcohol dependence; 3) severe medical conditions (e.g., cardiovascular or endocrine disease); 4) olfactory dysfunction; or 5) initiation, discontinuation, or dose adjustment of medications known to affect cognitive function during 3 months prior to consent or throughout the intervention period, including cognitive enhancers (e.g., donepezil, rivastigmine, galantamine, memantine) and major Central Nervous System-acting drugs (e.g., strong anticholinergics, antipsychotics, benzodiazepines/hypnotics, anticonvulsants). Written informed consent was obtained after participants were informed of the study’s purpose, procedures, and ethical considerations.
Participants were assigned to the experimental group, and the control group was matched for age and sex. This study included 50 participants, with 25 in each group.

Measurements

Cognitive performance was set as the primary focus to evaluate the effects of the NBI on older adults with MCI. Furthermore, emotional status, physical function, and physiological indicators were also assessed to examine additional outcomes.

Cognitive function

To assess cognitive function, this study used selected subtests from the Korean version of the Consortium to Establish a Registry for Alzheimer’s Disease Neuropsychological Battery, originally developed by a U.S. NIH-supported consortium [26] and later standardized in Korea by Lee et al. [27] It evaluated language, memory, visuospatial, and executive functions through subtests, such as the Mini-Mental State Examination (MMSE), Stroop Test, and semantic verbal fluency. Internal consistency was reported as Cronbach’s α=0.92 [27].
The MMSE-KC, Stroop Test, and semantic verbal fluency were selected as key indicators of general cognitive function. An arithmetic task (addition and subtraction) was included to assess numerical processing.
The MMSE, a widely used screening tool for neurocognitive disorders, measures various domains, such as orientation, memory, attention, and language. The total score ranges from 0 to 30 points. The MMSE is a reliable index of global cognition that is frequently used to monitor cognitive changes over time [28].
The Stroop Test evaluates attention, executive function, and inhibitory control via three subtasks: Word, Color, and Interference. Each is scored based on the number of correct responses within 1 minute [29,30].
Semantic verbal fluency was measured via an animal-naming task, which evaluated lexical retrieval and semantic memory access under time pressure [31]. Participants named as many animals as possible in 1 minute; invalid or repeated responses were excluded.
Arithmetic ability was assessed via two tasks: Addition & Subtraction_retrieval (ASr), which required direct recall of simple sums, and Addition & Subtraction_procedural (ASp), which involved multi-step calculations. These tasks served as task-based measures that reflected the cognitive demands of working memory and executive functions in arithmetic problem solving [32].

Emotional function

Emotional status was assessed via the Korean version of the Geriatric Depression Scale Short Form (SGDSSF-K), developed by Yesavage et al. [33] and translated by Kee [34]. This 15-item binary response scale yielded higher scores for more severe depressive symptoms. It demonstrated strong reliability in older adult populations (Cronbach’s α=0.88) [34].

Physical function

Physical performance was measured via the Short Physical Performance Battery (SPPB), which included tests of balance, gait speed, and chair stands. Scores range from 0 to 12 points, and lower scores indicate poorer physical function [35]. The SPPB demonstrated excellent internal consistency (α=0.86) and test-retest reliability (intraclass correlation [ICC]=0.92) [35]. Additionally, the Timed Up and Go (TUG) test was employed to assess mobility and balance. It measured the time taken to stand up, walk 3 m, return, and sit down [36]. It demonstrated good test-retest reliability (ICC=0.98) and internal consistency (α=0.81) [37].

Blood pressure

Blood pressure was measured as a physiological indicator. Systolic pressure below 120 mm Hg and diastolic pressure below 80 mm Hg were considered normal. In older adults, values up to 140/90 mm Hg may be acceptable due to age-related changes. Elevated blood pressure was associated with an increased risk of dementia [38].

Intervention

Intervention design

The NBI program comprised four weekly sessions (100- 110 minutes each), conducted in small groups of 3-5 participants. All sessions were led by certified forest therapy instructors who followed a standardized protocol. Group-based format aimed to promote social engagement and active participation.

Study site

Sessions were conducted at the National Center for Forest Education Chuncheon in Gangwon-do, South Korea. The site encompasses approximately 335 hectares of mixed coniferous and deciduous forest, where pine and oak species dominate, accompanied by diverse native shrubs and trees. The forest ecosystem also supports rich understory vegetation, herbaceous species, streams, birds, and insects, offering a high level of ecological diversity. Seasonal landscape changes, plant scents, and the natural sounds of flowing water and birds provide multisensory stimuli characteristic of a nature-based restorative environment suitable for cognitive recovery.
The main activity trail is located at an elevation of 188-227 m, with an average gradient of 2.3°-2.9°, forming a gently sloping 3-km round-trip path. Some sections are equipped with barrier-free deck trails, ensuring accessibility and walking safety for older adults. The facility also includes a visitor center, auditorium, cafeteria, and lawn plaza, allowing flexible indoor-outdoor program operation depending on weather conditions.
The site provided ecologically diverse environments and safe, barrier-free facilities. Rich sensory stimuli, natural scenery, seasonal aromas, and ambient sounds enhanced the setting’s suitability for cognitive recovery in older adults. The site was accessible through a memorandum of understanding with the National Center for Forest Education Chuncheon.

NBI program

The intervention was grounded in the theory that sensory stimulation and emotional relaxation in nature supported cognitive restoration [39]. Natural settings, such as forests, reduced emotional stress and enhanced attention and working memory [40]. To reflect these restorative effects, the program incorporated forest walking, nature-based exercises, sensory play, reminiscence activities, and structured observational tasks (Table 1).

Statistical analysis

All statistical analyses were conducted using SPSS WIN version 26.0 (IBM Corp.). Group homogeneity was tested via independent t-tests and chi-square tests. Fisher’s exact test was applied when the expected frequency was <5. Normality was assessed using the Shapiro-Wilk test. A Mann-Whitney U test was applied when normality was not satisfied. To evaluate intervention effects, a repeated-measures analysis of variance (ANOVA) was performed with group and time as the betweensubjects and within-subjects factors, respectively. Within-group pre-post comparisons were analyzed using paired samples ttests. Statistical significance was set at p<0.05.

RESULTS

Baseline demographic and clinical characteristics and homogeneity between groups

A total of 50 participants were assigned equally to the experimental and control groups, with matching by age and sex. Three participants in the experimental group withdrew due to incomplete intervention attendance, and three in the control group did not complete the post-assessment, yielding a final sample size of 44 (Table 2).

Cognitive effects

Repeated measures ANOVA on the MMSE scores revealed a statistically significant interaction between group and time (F=10.226, p=0.003), which indicated differing patterns of score changes between the experimental and control groups. Additional paired t-tests showed a significant increase in MMSE scores in the experimental group (t=-2.270, p=0.034), whereas the control group exhibited a significant decline (t=2.262, p=0.034). These results are visually summarized in Figure 2, which illustrates the divergent post-intervention trends between the two groups.
Although no significant interaction between time and group was observed in the ASr, ASp, and Stroop Color (SC) tasks, a significant main effect of time was observed. Additional within-group comparisons revealed significant pre-post improvements only in the experimental group post-intervention. For Stroop Word, the main effect of time was significant; however, the paired t-test revealed no significant difference between pre- and post-intervention scores. No significant effects were observed for Stroop Interference and Verbal Fluency_Semantic (Table 3).

Emotional effects

Analysis of the SGDS scores revealed a marginally significant interaction effect between group and time (F=3.885, p=0.055), although it did not reach statistical significance. Neither the main effects of group (F=1.222, p=0.275) nor time (F=3.803, p=0.058) were statistically significant. However, additional paired t-tests indicated a significant reduction in the SGDS scores within the experimental group (t=2.444, p=0.023), while no significant change was observed in the control group (t=-0.018, p=0.986) (Table 4).

Physical effects

Both the SPPB and TUG test revealed no significant main effects of group or time, nor any significant interaction effects between group and time (Table 5).

Blood pressure

No statistically or clinically significant changes in blood pressure were observed between the groups. Furthermore, no significant group, time, or interaction effects were observed (Table 6).

DISCUSSION

This study aimed to empirically examine the effects of an NBI on cognitive function in older adults with MCI and compared an intervention group with a control group. Results revealed that the MMSE, used as a representative indicator of cognitive function, significantly improved in the intervention group post-intervention compared with the control group, which demonstrated a statistically significant interaction effect between time and group. In contrast, emotional, physiological, and physical function indicators had no significant interaction effects.
Improvement in the MMSE scores was statistically significant and clinically meaningful. The MMSE is a widely used screening tool to diagnose neurocognitive disorders and evaluate intervention effects. It provides a structured quantification of overall cognitive status, and score changes may reflect actual functional improvements. Previous research revealed that improvements in MMSE scores were significantly associated with enhanced functional independence and better performance in activities of daily living [41-43].
Since its high test-retest reliability and inter-rater agreement make it suitable for tracking changes through repeated assessments, even short-term improvements in scores may serve as objective indicators of positive cognitive effects resulting from therapeutic or intervention programs [44,45].
Cummings [46] synthesized evidence from earlier studies and reported that a change of 1.2-2.6 points in the MMSE score may represent the Minimally Clinically Important Difference (MCID) for patients with MCI or mild Alzheimer’s disease. In this study, the MMSE score in the experimental group increased by approximately 1.2 points, close to the lower bound of the reported MCID and beyond the range of natural variability (±0.5 points), which suggested that the change may be interpreted as meaningful [45,47]. Therefore, significant improvement in the MMSE scores observed in the experimental group suggested that the NBI had a positive impact on cognitive function in older adults with MCI. Since MCI represents a critical window in which early intervention can delay progression to dementia, the clinical significance of interventions that promote cognitive improvement is particularly noteworthy [28].
Improvement in cognitive function may result from the combined effects of multiple factors inherent in natural environments [48]. Environmental stimuli are important contributors to improvements in attention and executive function, and natural settings provide sensory inputs that enhance both selective attention and executive functioning [40,49]. Sounds of nature and landscapes promote emotional stability and sustained attention [50-52]. According to Kaplan and Berman [53], natural environments facilitate the activation of involuntary attention, which enables recovery from attentional fatigue and improves direct attention and executive control. Considering these previous findings, NBIs may potentially influence cognitive function by engaging attention and executive processes. In this study, although no significant interaction effects were observed between the groups, within-group improvements were observed in the ASr, ASp, and SC tasks, which were closely related to attention and executive function. However, further research should clarify how NBIs influence attention and executive function and lead to cognitive improvements.
Another potential environmental factor is the influence of volatile organic compounds present in forest air, particularly phytoncides, known as therapeutic agents in forest environments [54]. According to recent research, inhalation of phytoncides in patients with MCI improved performance on the Stroop task. Furthermore, functional near-infrared spectroscopy revealed more efficient cognitive task performance in the phytoncide group, as evidenced by reduced oxygen consumption in the left ventrolateral prefrontal cortex [55]. Since participants in this study were repeatedly exposed to forest environments, similar neurophysiological mechanisms could have been at play. Although no significant between-group differences were observed, significant within-group improvements in Stroop performance in the intervention group suggested that phytoncide exposure may have contributed to enhanced prefrontal cortical activation.
Taken together, these findings suggest that restorative elements of natural environments—such as attention restoration and exposure to forest-derived chemical compounds—may contribute to improved cognitive function. However, these mechanistic explanations remain hypothetical and require targeted experimental investigation. Future research employing powered randomized controlled trials will be critical for confirming these preliminary findings and refining estimates of the observed effects.
Natural environments are considered complex stimulus settings that may indirectly contribute to changes in cognitive function by providing emotional stimuli that promote psychological stability as well as physical contexts that encourage bodily activity [14,56,57]. However, in this study, no significant between-group differences were observed in emotional, physical, or physiological indicators. Previous studies reported that activities in forest environments provided opportunities for sensory stimulation, physical movement, and social interaction, which positively influenced the reduction of depressive symptoms [14,57]. Although no significant differences were observed between groups, significant improvements in depressive symptoms were observed within the group that participated in NBI. This may be attributed to the higher baseline level of depression in the experimental group compared with the control group, which suggested that the intervention was more effective in reducing depressive symptoms among those with greater initial vulnerability. Therefore, future research should apply such interventions to populations with higher emotional vulnerability, such as those with clinical depression, for further refined analysis.
Regarding physical function, no significant changes were observed in either the SPPB or TUG test. The relatively short duration of the four-week intervention and its low physical intensity may not have provided sufficient physiological stimulation to induce measurable improvements. Nishiguchi et al. [58] reported significant improvements in SPPB scores after an eight-week forest-based aerobic exercise program, which suggested that longer and further intensive interventions may be necessary to produce observable effects on physical performance. Furthermore, this study employed gross functional assessments focused on gait and mobility. In contrast, Baek et al. [15] employed various physical assessments, which included body composition analysis via bioelectrical impedance, grip strength measurement via standardized resistance tests, balance assessment through postural sway analysis, and detailed gait evaluation that focused on stride length and walking speed. Their study demonstrated significant improvements in muscle mass, balance ability, and gait stability across most measured domains. These findings suggest that the absence of significant effects in this study may partly reflect limitations in both the sensitivity of the physical assessment tools and intervention dosage. Future studies should consider incorporating further sensitive and diverse measures of physical function and designing interventions with greater intensity and duration to better evaluate the full impact of nature-based programs on physical health.
Conclusively, this study is meaningful because it experimentally verified the effects of a NBI on cognitive improvement in older adults with MCI. Although MCI is characterized by noticeable cognitive decline, therapeutic options to prevent further deterioration remain limited. This study applied a non-pharmacological, non-invasive, and easily accessible intervention grounded in daily life and presented a practical method to enhance or maintain cognitive function in this population. Such an approach offers advantages regarding spatial accessibility and feasibility, which makes it a valuable option for real-life implementation. Therefore, continued research on systematic and long-term NBIs for older adults with MCI can substantially contribute to dementia prevention efforts and the development of community-based health promotion programs.
A limitation of this study is the intervention’s relatively short duration (4 weeks). Although nature-based activities demonstrated potential for positive changes in cognitive function, no significant between-group differences were observed in emotional, physiological, or physical function indicators. These health outcomes typically require more time to manifest measurable effects. Particularly, repeated stimulation, sufficient intensity of physical activity, and prolonged exposure are often necessary to induce meaningful change in physiological and physical function. This study employed an age- and sexmatched case-control design, with 25 participants per group. Within this design, the relatively small sample size reflects the exploratory nature of early-phase research. Prior studies have similarly used small samples: for example, Baek et al. [15] investigated 22 older adults with MCI without a control group, and Park et al. [59] examined 33 older adults with cognitive concerns using a controlled design. These precedents demonstrate that comparable or smaller sample sizes are common at this exploratory stage. However, small samples limit statistical precision and generalizability; therefore, the results should be interpreted cautiously. Given that the interpretation of mixed outcomes depends in part on how clearly environmental exposure and intervention intensity are defined, future research should standardize and quantify the reporting of study-site characteristics and intervention dose and intensity in alignment with experimental design principles.

Notes

Availability of Data and Material

The datasets generated or analyzed during the study are available from the corresponding author on reasonable request.

Conflicts of Interest

The authors have no potential conflicts of interest to disclose.

Author Contributions

Conceptualization: Do Hoon Kim, Eunkyung Kwan. Data curation: Eunkyung Kwan, Ara Cho. Formal analysis: Seungchan Park. Funding acquisition: Do Hoon Kim, Jungkee Choi. Investigation: Eunkyung Kwan, Ara Cho, Seungchan Park. Methodology: Ara Cho, Seungchan Park. Project administration: Do Hoon Kim, Jungkee Choi. Resources: Do Hoon Kim, Jungkee Choi. Software: Seungchan Park, Eunkyung Kwan. Supervision: Do Hoon Kim, Jungkee Choi. Validation: Ara Cho. Visualization: Eunkyung Kwan, Ara Cho. Writing—original draft: Eunkyung Kwan, Ara Cho. Writing—review & editing: Seungchan Park, Do Hoon Kim.

Funding Statement

This research was supported by the Hallym University Research Fund, R&D Program for Forest Science Technology (No. 2021402B10-2123-0101), provided by Korea Forest Service (Korea Forestry Promotion Institute), the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Government of Korea (No. 2021R1I1A3058026).

Acknowledgments

None

Figure 1.
Study design for evaluating the effects of nature-based intervention on MCI patients. MCI, mild cognitive impairment; Cont., control group; Exp., experimental group.
pi-2025-0294f1.jpg
Figure 2.
Changes in MMSE scores by group and time. A: Interaction effect between group and time. B: Within-group comparisons. *p<0.05; **p<0.01. MMSE, Mini-Mental State Examination; Exp., experimental group; Cont., control group.
pi-2025-0294f2.jpg
Table 1.
Structure of NBI program for older adults with MCI
Session Time (min) Program Description
1st 15 Orientation and Bonding Group introduction and orientation to build rapport
30 Positive Engagement Through Movement Stretching and postural exercises
30 Mindful Forest Walking Slow walking combined with attentional cues for observing the natural environment
30 Natural Object Sensory Play Exploring forest objects to awaken senses
2nd 15 Warm-up for Forest Activity Forest-based gait alignment and rhythmic joint mobilization exercises
30 Rope Play & Nature Sitting Rope-based movement, calm forest sitting for sensory and emotional balance
20 Olfactory and Tactile Stimulation Tactile and olfactory stimulation with natural elements
40 Reminiscence Walk A walking activity that evokes memories through natural stimuli
3rd 15 Dynamic Gait Preparation Postural correction, limb coordination, breathing-focused warm-up
40 Rhythmic Forest Walking A dynamic forest walk promoting balance, breathing, and rhythm
20 Cognitive Nature Exploration Forest treasure hunt with cognitive and sensory tasks
30 Reconnecting with Visual Nature Observing visual elements in nature to evoke memories
4th 15 Somatic Readiness Posture preparing for balanced walking
40 Walk toward the Future Practicing rebalancing walk with a mindset toward the future
30 Resting in the Forest Applying red clay for sensory grounding
30 Natural Object Sensory Play Tactile play with diverse natural materials

NBI, nature-based intervention; MCI, mild cognitive impairment.

Table 2.
General characteristics and homogeneity test between Exp. and Cont.
Variable Exp. (N=22) Cont. (N=22) t/u/χ² p
Age (yr) 76.95±5.71 75.13±6.09 1.190 0.313
Sex 0.393 0.531
 Male 9 (40.9) 7 (31.8)
 Female 13 (59.1) 15 (68.2)
Education 4.357* 0.379
 Below elementary school 5 (22.7) 5 (22.7)
 Elementary school-below middle school 4 (18.2) 9 (40.9)
 Middle school-below high school 2 (9.1) 3 (13.6)
 High school-below university 7 (31.8) 3 (13.6)
 University graduate or higher 4 (18.2) 2 (9.1)
Smoking (packs/day) 0.02±0.06 0.01±0.06 232 0.610
Drinking (times/wk) 0.07±0.23 0.14±0.43 231 0.685
Clinical Dementia Rating 0.52±0.19 0.50±0.0 241 0.981
Global Deterioration Scale 2.91±0.90 2.68±0.60 216 0.503
Mini-Mental State Examination 21.95±4.71 23.14±5.49 0.766 0.448
Short Blessed Test 8.00±7.70 8.00±7.34 241 >0.999
Instrumental Activities of Daily Living 0.25±0.32 0.27±0.32 213 0.498
Addition & Subtraction_retrieval 17.00±9.65 15.09±11.28 -0.603 0.550
Addition & Subtraction_procedural 6.41±4.26 6.01±4.64 -0.300 0.765
Stroop Word 78.86±22.34 70.09±24.53 -1.240 0.222
Stroop Color 63.27±19.62 61.91±20.74 -0.224 0.824
Stroop Interference 29.73±10.02 30.14±17.21 0.096 0.924
Verbal Fluency_Semantic 11.77±5.58 13.32±5.58 0.965 0.340
Geriatric Depression Scale Short Form 6.59±4.38 4.41±4.04 -1.716 0.093
Diastolic Blood Pressure 71.18±13.79 77.45±8.16 1.836 0.073
Systolic Blood Pressure 131.30±18.24 142.11±20.60 1.844 0.072
Short Physical Performance Battery 9.05±1.73 10.08±1.92 1.878 0.067
Timed Up & Go 12.50±3.70 11.61±2.22 -0.971 0.337

Values are presented as mean±standard deviation or N (%). Shapiro-Wilk test indicated violation of normality (p<0.001).

* Fisher’s exact test;

Mann-Whitney U test.

Exp., experimental group; Cont., control group.

Table 3.
Effects of nature-based intervention on cognitive variables
Group Pre Post Paired t-test
ANOVA
t p Source F p
MMSE Exp. (N=22) 21.95±4.71 23.14±5.27 -2.270 0.034* Group 0.003 0.958
Time 0.039 0.844
Cont. (N=22) 23.14±5.49 21.80±4.64 2.262 0.034* G×T 10.226 0.003**
ASr Exp. (N=22) 17.00±9.65 19.36±10.71 -2.853 0.010** Group 0.829 0.368
Time 6.069 0.018*
Cont. (N=22) 15.09±11.28 15.58±10.48 -0.601 0.554 G×T 2.639 0.112
ASp Exp. (N=22) 6.41±4.26 7.55±4.54 -3.087 0.006** Group 0.473 0.495
Time 4.286 0.045*
Cont. (N=22) 6.01±4.64 6.06±5.10 -0.128 0.900 G×T 3.511 0.068
SW Exp. (N=22) 78.86±22.34 81.55±21.75 -1.561 0.133 Group 1.568 0.217
Time 5.051 0.030*
Cont. (N=22) 70.09±24.52 73.80±20.72 -1.637 0.117 G×T 0.131 0.720
SC Exp. (N=22) 63.27±19.97 67.09±17.66 -2.526 0.020* Group 0.078 0.781
Time 7.734 0.008**
Cont. (N=22) 61.91±20.74 65.30±18.53 -1.610 0.122 G×T 0.027 0.870
SI Exp. (N=22) 29.73±10.02 31.18±15.81 -0.761 0.455 Group 0.042 0.838
Time 2.106 0.154
Cont. (N=22) 30.14±17.21 32.55±16.05 -1.298 0.208 G×T 0.130 0.720
VS Exp. (N=22) 11.77±5.58 12.18±4.85 -0.443 0.662 Group 0.607 0.440
Time 0.000 0.984
Cont. (N=22) 13.32±5.03 12.93±5.52 0.549 0.589 G×T 0.469 0.497

Values are presented as mean±standard deviation. Repeated measures ANOVA was performed to examine group, time, and their interaction. Paired t-tests were conducted within each group to assess pre-post changes.

* p<0.05;

** p<0.01.

ANOVA, analysis of variance; Exp., experimental group; Cont., control group; MMSE, Mini-Mental State Examination; ASr, Addition & Subtraction_retrieval; ASp, Addition & Subtraction_procedural; SW, Stroop Word; SC, Stroop Color; SI, Stroop Interference; VS, Verbal Fluency_Semantic.

Table 4.
Effects of nature-based intervention on emotional variable
Var. Group Pre Post Paired t-test
ANOVA
t p Source F p
SGDS Exp. (N=22) 6.59±4.38 4.68±3.47 2.444 0.023* Group 1.222 0.275
Time 3.803 0.058
Cont. (N=22) 4.41±4.04 4.42±4.08 -0.018 0.986 G×T 3.885 0.055

Values are presented as mean±standard deviation. Repeated measures ANOVA was performed to examine group, time, and their interaction. Paired t-tests were conducted within each group to assess pre-post changes.

* p<0.05.

ANOVA, analysis of variance; Exp., experimental group; Cont., control group; SGDS, Geriatric Depression Scale Short Form.

Table 5.
Effects of nature-based intervention on physical variables
Var. Group Pre Post Paired t-test
ANOVA
t p Source F p
SPPB Exp. (N=22) 9.05±1.73 9.14±1.52 1.853 0.078 Group 0.111 0.741
Time 2.640 0.112
Cont. (N=22) 10.08±1.92 8.55±4.37 -0.283 0.780 G×T 3.347 0.074
TUG Exp. (N=22) 12.50±3.70 12.16±2.84 -0.494 0.627 Group 0.575 0.453
Time 0.011 0.918
Cont. (N=22) 11.61±2.22 11.86±2.84 0.529 0.602 G×T 0.521 0.474

Values are presented as mean±standard deviation. Repeated measures ANOVA was performed to examine group, time, and their interaction. Paired t-tests were conducted within each group to assess pre-post changes. ANOVA, analysis of variance; Exp., experimental group; Cont., control group; SPPB, Short Physical Performance Battery; TUG, Timed Up & Go.

Table 6.
Effects of nature-based intervention on physiological variables
Var. Group Pre Post Paired t-test
ANOVA
t p Source F p
BPs Exp. (N=22) 131.30±18.23 134.48±17.98 -0.950 0.353 Group 3.402 0.072
Time 0.567 0.456*
Cont. (N=22) 142.11±20.60 143.20±22.55 -0.238 0.814 G×T 0.136 0.714
BPd Exp. (N=22) 71.18±13.78 70.03±12.34 0.644 0.527 Group 3.462 0.070
Time 1.813 0.185
Cont. (N=22) 77.45±8.16 74.94±8.34 1.225 0.234 G×T 0.252 0.619

Values are presented as mean±standard deviation. Repeated measures ANOVA was performed to examine group, time, and their interaction. Paired t-tests were conducted within each group to assess pre-post changes.

* p<0.05.

ANOVA, analysis of variance; Exp., experimental group; Cont., control group; BPs, systolic blood pressure; BPd, diastolic blood pressure.

REFERENCES

1. Statistics Korea. Statistics on the elderly 2024. [Internet] Available at: https://mods.go.kr/board.es?mid=a10301010000&bid=10820&act=view&list_no=432917. Accessed October 30, 2025.

2. Kelly ME, Duff H, Kelly S, McHugh Power JE, Brennan S, et al. The impact of social activities, social networks, social support and social relationships on the cognitive functioning of healthy older adults: a systematic review. Syst Rev 2017;6:259
crossref pmid pmc pdf
3. Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L. Mild cognitive impairment: a concept in evolution. J Intern Med 2014;275:214-228.
crossref pmid pmc pdf
4. Tricco AC, Soobiah C, Berliner S, Ho JM, Ng CH, Ashoor HM, et al. Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis. CMAJ 2013;185:1393-1401.
crossref pmid pmc
5. Karakaya T, Fußer F, Schröder J, Pantel J. Pharmacological treatment of mild cognitive impairment as a prodromal syndrome of Alzheimer’s disease. Curr Neuropharmacol 2013;11:102-108.
crossref pmid pmc
6. Fink HA, Jutkowitz E, McCarten JR, Hemmy LS, Butler M, Davila H, et al. Pharmacologic interventions to prevent cognitive decline, mild cognitive impairment, and clinical Alzheimer-type dementia: a systematic review. Ann Intern Med 2018;168:39-51.
crossref pmid pdf
7. Ibrahim MMA. Mild cognitive impairment in older adults: predictors, diagnosis, and management. Int J Psychol Sci 2025;7:36-45.
crossref
8. Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, et al. Practice guideline update summary: mild cognitive impairment [RETIRED]: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 2018;90:126-135.
crossref pmid pmc
9. Kang C. Donanemab: first approval. Drugs 2024;84:1313-1318.
crossref pmid pdf
10. Honig LS, Sabbagh MN, van Dyck CH, Sperling RA, Hersch S, Matta A, et al. Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease. Alzheimers Res Ther 2024;16:105
crossref pmid pmc pdf
11. Shanahan DF, Astell-Burt T, Barber EA, Brymer E, Cox DTC, Dean J, et al. Nature-based interventions for improving health and wellbeing: the purpose, the people and the outcomes. Sports (Basel) 2019;7:141
crossref pmid pmc
12. Jiang H, Eaglestone G, McCrone P, Carr C, Stoner C. How are naturebased interventions defined in mild cognitive impairment and dementia studies? A conceptual systematic review and novel taxonomy. Dementia (London) 2025;24:480-505.
crossref pmid pmc pdf
13. Sia A, Tam WWS, Fogel A, Kua EH, Khoo K, Ho RCM. Nature-based activities improve the well-being of older adults. Sci Rep 2020;10:18178
crossref pmid pmc pdf
14. Lee MJ, Kim SY, Choi JK. [The effect of forest therapy program on the cognitive function of the elderly]. The Journal of Korean Institute of Forest Recreation 2021;25:25-34. Korean.

15. Baek JE, Jung JH, Shin HJ, Kim SH, Sung SY, Park SJ, et al. Effects of forest healing anti-aging program on psychological, physiological, and physical health of older people with mild cognitive impairment. Int J Environ Res Public Health 2022;19:4863
crossref pmid pmc
16. Stenfors CUD, Van Hedger SC, Schertz KE, Meyer FAC, Smith KEL, Norman GJ, et al. Positive effects of nature on cognitive performance across multiple experiments: test order but not affect modulates the cognitive effects. Front Psychol 2019;10:1413
crossref pmid pmc
17. Sahni P, Kumar J. Effect of nature experience on fronto-parietal correlates of neurocognitive processes involved in directed attention: an ERP study. Ann Neurosci 2020;27:136-147.
crossref pmid pmc pdf
18. Kühn S, Forlim CG, Lender A, Wirtz J, Gallinat J. Brain functional connectivity differs when viewing pictures from natural and built environments using fMRI resting state analysis. Sci Rep 2021;11:4110
pmid pmc
19. Yi ES, Ahn CW. [Effect of leisure sports participation on the successful aging of elderly: analysis of the intermediating effect of resilience]. Korean J Phys Educ 2010;49(4):325-337. Korean.

20. Chae YR, Lee SH. Systematic review of forest therapy program for adult patients with diseases. J Korean Biol Nurs Sci 2020;22:157-171.
crossref
21. Jun AY, Lee KS, Lee SM. Effects of the forest experience intervention program on depression, cognitive function, and quality of life in the elderly people with mild cognitive impairment. Korean J Health Educ Promot 2019;36(3):73-82. Korean.
crossref
22. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. Arlington: American Psychiatric Association; 2013.

23. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.
crossref pmid
24. Reisberg B, Ferris SH, de Leon MJ, Crook T. Global Deterioration Scale (GDS). Psychopharmacol Bull 1988;24:661-663.
pmid
25. Berg L. Clinical dementia rating. Br J Psychiatry 1984;145:339
crossref pmid
26. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, et al. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology 1989;39:1159-1165.
crossref pmid
27. Lee JH, Lee KU, Lee DY, Kim KW, Jhoo JH, Kim JH, et al. Development of the Korean version of the Consortium to Establish a Registry for Alzheimer’s Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci 2002;57:P47-P53.
crossref pmid
28. Arevalo-Rodriguez I, Smailagic N, Roqué I Figuls M, Ciapponi A, Sanchez-Perez E, Giannakou A, et al. Mini-Mental State Examination (MMSE) for the detection of Alzheimer’s disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev 2015;(3):CD010783
crossref pmid pmc
29. Stroop JR. Studies of interference in serial verbal reactions. Journal of Experimental Psychology 1935;18:643-662.
crossref
30. Zhang HY, Wang SJ, Liu B, Ma ZL, Yang M, Zhang ZJ, et al. Resting brain connectivity: changes during the progress of Alzheimer disease. Radiology 2010;256:598-606.
crossref pmid
31. Shao Z, Janse E, Visser K, Meyer AS. What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults. Front Psychol 2014;5:772
crossref pmid pmc
32. Zamarian L, Ischebeck A, Delazer M. Neuroscience of learning arithmetic--evidence from brain imaging studies. Neurosci Biobehav Rev 2009;33:909-925.
crossref pmid
33. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982;17:37-49.
crossref pmid
34. Kee BS. [A preliminary study for the standardization of geriatric depression scale short form-Korea version]. J Korean Neuropsychiatr Assoc 1996;35:298-307. Korean.

35. Guralnik JM, Seeman TE, Tinetti ME, Nevitt MC, Berkman LF. Validation and use of performance measures of functioning in a non-disabled older population: MacArthur studies of successful aging. Aging (Milano) 1994;6:410-419.
crossref pmid pdf
36. Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991;39:142-148.
crossref pmid pmc
37. Aslankhani MA, Farsi AR, Fathirezaie Z, Zamani Sani SH, Aghdasi MT. [Validity and reliability of the timed up and go and the anterior functional reach tests in evaluating fall risk in the elderly]. Iranian Journal of Ageing 2015;10:16-25. Persian.

38. Lee HY. New definition for hypertension. J Korean Med Assoc 2018;61:485-492.
crossref pdf
39. Stevenson MP, Schilhab T, Bentsen P. Attention Restoration Theory II: a systematic review to clarify attention processes affected by exposure to natural environments. J Toxicol Environ Health B Crit Rev 2018;21:227-268.
crossref pmid
40. Berman MG, Jonides J, Kaplan S. The cognitive benefits of interacting with nature. Psychol Sci 2008;19:1207-1212.
crossref pmid pdf
41. Heyman N, Tsirulnicov T, Ben Natan M. Prediction of geriatric rehabilitation outcomes: comparison between three cognitive screening tools. Geriatr Gerontol Int 2017;17:2507-2513.
crossref pmid pdf
42. Toba K, Nakamura Y, Endo H, Okochi J, Tanaka Y, Inaniwa C, et al. Intensive rehabilitation for dementia improved cognitive function and reduced behavioral disturbance in geriatric health service facilities in Japan. Geriatr Gerontol Int 2014;14:206-211.
pmid
43. Stavrinou PS, Aphamis G, Pantzaris M, Sakkas GK, Giannaki CD. Exploring the associations between functional capacity, cognitive function and well-being in older adults. Life 2022;12:1042
crossref pmid pmc
44. Lee DY, Lee KU, Lee JH, Kim KW, Jhoo JH, Yoon JC, et al. [A normative study of the Mini-Mental State Examination in Korean elderly]. J Korean Neuropsychiatr Assoc 2002;41:508-525. Korean.

45. Song M, Kim J, Ryu K, Kim J, Rie J, Kang Y. The influence of test-retest interval on the significant change indices for the K-MMSE. Dement Neurocogn Disord 2012;11:146-153. Korean.
crossref
46. Cummings J. Perspective: minimal clinically important difference (MCID) and Alzheimer’s disease clinical trials. Alzheimers Dement (N Y) 2025;11:e70059
crossref pmid pmc
47. Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc 1992;40:922-935.
crossref pmid
48. Schertz KE, Berman MG. Understanding nature and its cognitive benefits. Curr Dir Psychol Sci 2019;28:496-502.
crossref pdf
49. Ottosson J, Grahn P. A comparison of leisure time spent in a garden with leisure time spent indoors: on measures of restoration in residents in geriatric care. Landscape Research 2005;30:23-55.
crossref
50. Van Hedger SC, Nusbaum HC, Clohisy L, Jaeggi SM, Buschkuehl M, Berman MG. Of cricket chirps and car horns: the effect of nature sounds on cognitive performance. Psychon Bull Rev 2019;26:522-530.
crossref pmid pdf
51. Ahmed H. The influence of environmental sounds on cognition and mood [Undergraduate thesis]. London: Huron University College; 2022.

52. Rhee JH, Schermer B, Han G, Park SY, Lee KH. Effects of nature on restorative and cognitive benefits in indoor environment. Sci Rep 2023;13:13199
crossref pmid pmc pdf
53. Kaplan S, Berman MG. Directed attention as a common resource for executive functioning and self-regulation. Perspect Psychol Sci 2010;5:43-57.
crossref pmid pdf
54. Thangaleela S, Sivamaruthi BS, Kesika P, Bharathi M, Kunaviktikul W, Klunklin A, et al. Essential oils, phytoncides, aromachology, and aromatherapy—a review. Appl Sci 2022;12:4495
crossref
55. Park S, Kim J, Kim H, Kim DH. Effects of phytoncide inhalation on Stroop task performance in patients with mild cognitive impairment: an fNIRS pilot study. Clin Psychopharmacol Neurosci 2025;23:42-52.
crossref pmid pmc
56. Lee HJ, Kahng SK. [The reciprocal relationship between cognitive functioning and depressive symptom: group comparison by gender]. Korean Journal of Social Welfare Studies 2011;42:179-203. Korean.
crossref
57. Kim ID, Koo CD. A study of walking, viewing and fragrance-based forest therapy programs effect on living alone adults’ dementia prevention. Korean J Environ Ecol 2019;33:107-115. Korean.
crossref
58. Nishiguchi S, Yamada M, Tanigawa T, Sekiyama K, Kawagoe T, Suzuki M, et al. A 12-week physical and cognitive exercise program can improve cognitive function and neural efficiency in community-dwelling older adults: a randomized controlled trial. J Am Geriatr Soc 2015;63:1355-1363.
crossref pmid pdf
59. Park J, Wang SM, Kang DW, Lee B, Choi H. Effect of anti-aging standard forest healing program with multiple visits to a forest facility on cognition in older age patients. Dement Neurocogn Disord 2024;23:44-53.
crossref pmid pmc pdf


ABOUT
AUTHOR INFORMATION
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
Editorial Office
#522, G-five Central Plaza, 27 Seochojungang-ro 24-gil, Seocho-gu, Seoul 06601, Korea
Tel: +82-2-537-6171  Fax: +82-2-537-6174    E-mail: psychiatryinvest@gmail.com                

Copyright © 2026 by Korean Neuropsychiatric Association.

Developed in M2PI

Close layer
prev next